Volitionrx Limited (NYSE: VNRX) reported Q1 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

Cash and cash equivalents as of March 31, 2016 totaled $17.0 million, compared with $5.9 million as of December 31, 2015.

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.